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The quorum sensing (QS) system of Bacillus cereus, an opportunistic human pathogen,
utilizes the autoinducing PapR peptide signal that mediates the activation of the
pleiotropic virulence regulator PlcR. A set of synthetic 7-mer PapR-derived peptides
(PapR7; ADLPFEF) have been shown to inhibit efficiently the PlcR regulon activity and
the production of virulence factors, reflected by a loss in hemolytic activity without
affecting bacterial growth. Interestingly, these first potent synthetic inhibitors involved
D-amino acid or alanine replacements of three amino acids; proline, glutamic acid, and
phenylalanine of the heptapeptide PapR. To better understand the role of these three
positions in PlcR activity, we report herein the second generation design, synthesis, and
characterization of PapR7-derived combinations, alternate double and triple alanine and
D-amino acids replacement at these positions. Our findings generate a new set of non-
native PapR7-derived peptides that inhibit the PlcR regulon activity and the production
of virulence factors. Using the amino acids substitution strategy, we revealed the role of
proline and glutamic acid on PlcR regulon activation. Moreover, we demonstrated that
the D-Glutamic acid substitution was crucial for the design of stronger PlcR antagonists.
These peptides represent potent synthetic inhibitors of B. cereus QS and constitute new
and readily accessible chemical tools for the study of the PlcR system. Our method
might be applied to other quorum sensing systems to design new anti-virulence agents.
Keywords: quorum sensing, quorum quenching, PlcR antagonists, B. cereus group, anti-virulence peptides
INTRODUCTION
Quorum sensing (QS) is a cell-cell communication mechanism used to coordinate bacterial group
behaviors (conjugation, virulence, sporulation, or competence) by assessing cell density through the
production, secretion, and detection of small signaling molecules (Dunny and Leonard, 1997; Miller
and Bassler, 2001; Slamti et al., 2014). Gram-negative bacteria appear to predominantly respond to
N-acyl homoserine lactones, while QS in Gram-positive species mainly relies on the secretion of
auto-inducing oligopeptides to bind and activate their cognate quorum sensors. In the past decade,
a rapid increase of interest in bacterial quorum sensing peptides (QSPs) has emerged. Therefore,
new QSPs databases are being established to provide chemical structures overview, microbial origin
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and functionality responses of these QS-derived signaling
peptides (Gray et al., 2013; Wynendaele et al., 2013;
Rajput et al., 2016).
The QSPs binding to their cognate quorum sensors occurs
either on the outside of the bacterium (by interacting with a
sensor in the membrane) or in the cytoplasm of the bacterial cell.
In the latter case, the quorum-sensing regulators are controlled by
direct interaction with a internalized signaling peptide (Dunny
and Leonard, 1997; Lazazzera et al., 1997; Gominet et al.,
2001; Miller and Bassler, 2001). They have been grouped in
a new family of quorum sensors termed Rap-Rgg-NprR-PrgX-
PlcR (RRNPP; Declerck et al., 2007; Neiditch et al., 2017).
These quorum sensors are characterized by the presence of
structural tetratricopeptide repeats (TPRs) forming a peptide
binding domain (Blatch and Lässle, 1999), and a helix-turn-
helix (HTH) DNA-binding domain (Wintjens and Rooman,
1996) in the case of transcriptional regulators. The PrgX –
cCF10 system regulates conjugation in Enterococcus faecalis
(Suzuki et al., 1984; Shi et al., 2005), the Rap phosphatases-
Phr peptides system control competence and sporulation in
Bacillus subtilis (Lazazzera et al., 1997; Perego and Brannigan,
2001; Perego, 2013), the transcriptional regulator/peptide pairs
PlcR – PapR and NprR – NprX of the Bacillus cereus group
are required for virulence and necrotrophism gene expression,
respectively (Slamti and Lereclus, 2002; Perchat et al., 2011;
Dubois et al., 2012; Grenha et al., 2013) and the archetype
transcriptional regulator of the Rgg family, namely ComR that
controls competence in most mutans, suis, pyogenes, bovis and
salivarius streptococci (Mashburn-Warren et al., 2010; Fontaine
et al., 2015) and predation in S. salivarius (Mignolet et al., 2018).
The last discovered RRNPP transcriptional regulators are the
PlcRa that activate the oxidative stress response and cysteine
metabolism in transition state cells in B. cereus (Huillet et al.,
2012) and aimR, which coordinates viruses of SPbeta group
lysis-lysogeny decisions during infection of its Bacillus host cell
(Erez et al., 2017).
The RRNPP family has an important role in adaptive
and virulence processes in several bacteria (Slamti et al.,
2014; Neiditch et al., 2017). This clearly identifies these
regulators as major targets for the search of novel strategies
against bacterial infections beyond conventional treatments.
Antimicrobial therapy based on quorum quenching (QQ) can
interfere or block all the processes involved in quorum sensing
(Amara et al., 2011; Kalia, 2013; Grandclément et al., 2015).
In contrast to antibiotics or antimicrobial agents, which aim
at killing bacteria or inhibiting their growth, blocking cell-to-
cell signaling mechanism, could attenuate bacterial pathogenicity
without imposing the level of selective pressure on a bacterial
population to develop resistance (Suga and Smith, 2003;
Rasmussen and Givskov, 2006). A wide range of promising
molecules have been already identified to inhibit QS-controlled
virulence genes in Gram-negative bacteria (Hentzer et al., 2003;
Galloway et al., 2012). On the other hand, except for strategies
that have been investigated to inhibit the two component QS
system Agr of Staphylococcus, which uses a peptide-thiolactone
as the extracellular signal, the design of molecules modulating
QS systems in Gram-positive bacteria has been poorly explored
(Fontaine et al., 2010; Zheng et al., 2011; Tal-Gan et al., 2013a,
2014, 2016; Sully et al., 2014).
Bacillus cereus is a human opportunistic, Gram-positive spore-
forming bacterial pathogen belonging to the B. cereus group
(Stenfors Arnesen et al., 2008). This group comprises a number
of highly phenotypically and genetically indistinguishable related
species, including Bacillus thuringiensis, an insect pathogen, and
Bacillus anthracis, the aetiological agent of anthrax (Helgason
et al., 2000). The widespread presence of B. thuringiensis and
B. cereus in soil and food, and their close relationship with
B. anthracis make this group an important threat to public health
(Rasko et al., 2005; Rossi et al., 2018), and a potential source
of new pathogens. Indeed, B. cereus is generally regarded as a
pathogen causing foodborne infections due to the production
of enterotoxins such as Hbl and Nhe (Stenfors Arnesen et al.,
2008), and nosocomial infections in an immuno-compromised
patients (Granum and Lund, 1997; Kotiranta et al., 2000; Chu
et al., 2001; Gaur et al., 2001; Bottone, 2010). B. cereus strains
were also found to be responsible for severe infections resembling
anthrax (Hoffmaster et al., 2004; Klee et al., 2006).
The QS system of B. cereus plays an important role in virulence
(Agaisse et al., 1999; Gohar et al., 2008). B. cereus uses QS to
establish infections by producing an arsenal of virulence factors,
such as enterotoxins, pore-forming haemolysins, cytotoxins and
various degradative enzymes (Granum and Lund, 1997; Vilas-
Boas et al., 2002; Stenfors Arnesen et al., 2008; Ramarao and
Sanchis, 2013). Production of most of these exported virulence
factors is activated by PlcR, a 34 kDa protein that acts as a
B. cereus group main virulence transcription factor (Lereclus
et al., 1996; Agaisse et al., 1999; ØKstad et al., 1999; Gohar et al.,
2008). Activity of PlcR depends on the binding of the signaling
C-terminal heptapeptide PapR7 (ADLPFEF) at the end of the
exponential growth stage. PapR7 is imported by the oligopeptide
permease system (OppABCDF; Gominet et al., 2001), binds the
tetratricopeptide repeat (TPR)-type regulatory domain of PlcR
(Grenha et al., 2013) and promotes recognition of the PlcR box to
transcriptional activation of the target genes (Lereclus et al., 1996;
Gominet et al., 2001; Slamti and Lereclus, 2002; Bouillaut et al.,
2008). This triggers a positive feedback loop that up-regulates
the expression of plcR, papR and various virulence genes (Agaisse
et al., 1999; Ivanova et al., 2003; Gohar et al., 2008).
The structural and molecular basis for the activation of PlcR
by PapR has been the focus of several studies, which have
revealed interesting insights on the PlcR – PapR interactions.
The PlcR – PapR relationship has been shown to be strain
specific; comparison of the amino acid sequences of PlcR and
PapR from 29 different strains demonstrated the existence of
four classes (I to IV) of PlcR – PapR pairs, defining four distinct
pherotypes in the B. cereus group. While PapR sequences from
different strains of the B. cereus group showed divergences
in their three N-terminal residues, the PFEF core was more
conserved (Slamti and Lereclus, 2005). In 2007, the crystal
structure of the complex formed between the protein PlcR (from
group I) and the C-terminal PapR5 pentapeptide (LPFEF) was
published (Declerck et al., 2007). According to RRNPP conserved
features, each subunit of PlcR is formed of an N-terminal HTH
DNA-binding domain, and a C-terminal regulatory domain
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composed of five degenerated TPRs forming a peptide binding
domain. Binding of PapR triggers an allosteric mechanism that
leads to a drastic conformational change of the HTH domains
upon the two half sites of the DNA binding site, known as
PlcR-box. The LPFEF pentapeptide, PapR5 was identified as
the minimal peptide size required for PlcR activation (Slamti
and Lereclus, 2002). However, the physiologically relevant
heptapeptide PapR7 displays a slightly better affinity for PlcR
(Bouillaut et al., 2008; Grenha et al., 2013). In 2008, Bouillaut
and co-workers established a molecular model for the complex
formed between PlcR and the heptapeptide PapR7 based on
the crystal structure of PapR5-bound PlcR (Declerck et al.,
2007; Bouillaut et al., 2008). Structural analysis and directed
mutagenesis of PlcR residues suggested that: a) activation of
PlcR by PapR7 is triggered by the hydrophobic interactions of
the leucine, and two phenylalanines with helices 5 and 7 of the
TPR-containing domain of PlcR b) the central proline residue
may be required for the PapR peptides to fit into the binding
groove on PlcR and c) the glutamic acid of the FEF PapR7
core motif may function to selectively allow PapR to bind PlcR
by ionic interactions with Lys87 and 89. In a follow up study
in 2013, Grenha and co-workers, have determined the crystal
structure of the ternary complex DNA-PlcR-PapR7. It has been
reported that both PapR7 phenylalanine residues are located in
hydrophobic pockets and the only specific interactions are made
between the glutamate of PapR7 and residues Lys89, Gln237,
and Tyr275 of PlcR.
Binding of PapR to PlcR is essential to trigger QS-mediated
functions in B. cereus. Thus, we recently studied the PlcR –
PapR activation in B. cereus and B. thuringiensis at the molecular
level. We designed, synthesized and characterized synthetic
PapR 7-mer derived peptides to determine the contribution of
each residue within PlcR – PapR7 interactions. Our findings
reveal the first set of non-native peptides that can repress the
PlcR regulon and thus relevant virulence factors. Moreover, we
could demonstrate that the repression is mediated by QS and
regulation of PlcR expression without affecting bacterial growth
(Yehuda et al., 2018). Interestingly, these first potent synthetic
inhibitors involved D-amino acid or alanine replacements of
either proline (P) glutamic acid (E) or phenylalanine (F)
of the heptapeptide PapR (ADLPFEF). To better understand
the role of these three crucial positions in PlcR activation,
we report herein the second generation design, synthesis,
and characterization of PapR7-derived combinations, alternate
double and triple alanine and D-amino acids replacement
at these positions. We propose this systematic replacement
approach to elucidate other quorum quenching agents in
Gram-positive bacteria.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bacterial strains used in this study: B. thuringiensis 407 Cry−
plcA′Z (Bt A’Z) and the PapR null-mutant 407 Cry− 1papR
plcA’Z (Bt 1papR A’Z) strains, containing a transcriptional
fusion between the promoter of plcA and the lacZ reporter
gene (as described previously; Gominet et al., 2001; Slamti and
Lereclus, 2002); B. cereus strain ATCC 14579 (Ivanova et al.,
2003). Unless otherwise noted, cells were grown in modified LB
medium (16 g/L tryptone, 8 g/L yeast extract, 5 g/L NaCl) at 37◦C
and stored at −80◦C in LB containing 25% glycerol. Kanamycin
(200 µg/mL) was used for the selection of B. thuringiensis.
Solid Phase Peptide Synthesis
Methodology (SPPS)
All the peptides were synthesized using standard Fmoc-based
solid-phase peptide synthesis (SPPS), microwave irradiation,
procedures on Rink Amide resin (substitution 0.5 mmol/g,
25 µmol) in SPE polypropylene Single-Fritted tubes. The Fmoc-
protecting group was then removed by treating the resin with
20% (v/v) piperidine diluted in dimethylformamide (DMF)
followed by heating to 80◦C in the microwave (MARS, CEM,
United States; 2-min ramp to 80◦C, 2-min hold at 80◦C) with
stirring. To couple each amino-acid, Fmoc-protected amino
acids (4 equiv. relative to the overall loading of the resin),
were dissolved in DMF and mixed with 2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU;
4 equiv.) and diisopropylethylamine (DIEA; 4 equiv.). The
solution was allowed to pre-activate for 5 min before being
added to the resin, and heated to 70◦C in a multimode
microwave (2-min ramp to 70◦C, 4-min hold at 70◦C) with
stirring. After each coupling/deprotection cycle the resin was
drained and washed with DMF (3 × 5 mL). Once peptide
synthesis was completed, the peptide was cleaved from the
resin, by mixing the resin with 3 mL cleavage cocktail of
95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane (TIPS),
and 2.5% deionized water for 3 h with agitation. The peptide
mixture was precipitated from the TFA solution by the addition
of cold ether and collected by centrifugation (Eppendorf
R5810 8000 rpm for 10 min). The ether was then removed,
and the peptide was dried under a stream of nitrogen, and
lyophilized, before high-performance liquid chromatography
(HPLC) purification.
Peptide Purification
Crude peptides were purified and characterized with Reverse-
Phase (RP)-HPLC. The crude peptides were diluted to a final
concentration of 10 mg/ml in a solution of 20% acetonitrile
(ACN) in water (v/v) or dimethyl sulfoxide (DMSO). A semi-
preparative Phenomenex Kinetex C18 (5 µm, 10× 250 mm) was
used for preparative RP-HPLC work. An analytical Phenomenex
Gemini C18 column (5 µm, 4.6 mm × 250 mm, 110
Å) was used for analytical RP-HPLC work (Supplementary
Figure S1). Standard RP-HPLC conditions were as follows:
flow rates = 5 mL min−1 for semi-preparative separations
and 1 mL min−1 for analytical separations; mobile phase
A = 18 M water + 0.1% TFA; mobile phase B = ACN.
Purities were determined by integration of peaks with UV
detection at 220 nm using a linear gradient (first prep 5%
B → 65% B over 60 min and second prep 26% B →
36% B over 20 min). The purity of the tested peptides
was determined using a linear gradient (5% B → 65% B
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over 60 min). MALDI-TOF spectrometry (Bruker Daltonik,
Germany) was used to validate the synthesized peptides
molecular weight (Supplementary Table S1). The purified
peptides were lyophilized and stored at−20◦C.
Analysis of PlcR Regulon Expression
Using β-Galactosidase Assay
PlcR Activation Studies
Bt 1papR A’Z cells were grown overnight in LB medium with
selective antibiotic. The cells were diluted 10−3 in modified LB
to a final volume of 1 liter and incubated at 37◦C with shaking
(200 rpm) until onset of the stationary phase of bacterial growth
(OD600 3 ± 0.5). Various concentrations of synthetic peptides
were added to 2 ml aliquots of culture, which were incubated for
1 h before centrifugation (Eppendorf centrifuge R5810, 4000 rpm
for 5 min) and quantification of β-galactosidase.
Competition Studies of PapR7-Derived Peptides
Bt A’Z cells were grown overnight in LB medium. The cells
were diluted 10−3 in modified LB to a final volume of 1 L and
incubated at 37◦C with shaking (200 rpm) until the end of the
lag or late-exponential of bacterial growth (OD600 0.1 ± 0.03;
1.8 ± 0.1, respectively). Different concentrations of synthetic
peptides were added to 2 ml aliquots of culture and incubated
for various times (1–24 h) before centrifugation (Eppendorf
centrifuge R5810, 4000 rpm for 5 min) and quantification of
β-galactosidase activity.
β-Galactosidase Assay
β-galactosidase activity was measured as described previously
(Yang et al., 2017), with minor modifications. Briefly, 200 µL
aliquots from 2 ml treated cultures were added in triplicate to
a clear 96-well microtiter plate, and then OD600 was measured
and β-galactosidase activity was assayed. The final results were
reported as percentage of activation, which is the ratio between
the Miller units obtained after addition of the PapR7 analogs.
In Bt 1papR A’Z strain, the plcA promoter activity was
very low and considered as a baseline. In Bt A’Z strain, the
untreated bacteria were considered as 100% of activation and the
results were normalized accordingly. Each assay was repeated at
least three times.
Hemolytic Assay Toward Human Red
Blood Cells
Bt A’Z or B. cereus ATCC 14579 cells were grown overnight
in LB medium. The cells were diluted 10−3 in modified LB
to a final volume of 1 liter and incubated at 37◦C with
shaking (200 rpm) until the end of the lag phase of bacterial
growth (OD600 0.1± 0.03). Different concentrations of synthetic
peptides were added to 2 ml aliquots of culture and incubated
for 2.5 h before centrifugation (Eppendorf centrifuge R5810,
4000 rpm for 5 min), separation and filtration (0.2 µm filter) of
the supernatants of the treated cultures. Analyses of hemolytic
activity were conducted as previously described using human red
blood cells (Tal-Gan et al., 2013b; Lobel et al., 2015). Bacterial
supernatants were serially diluted in Tris-buffered saline (pH
7.2, 10 mM Tris–HCl, 155 mM NaCl) with 1% human red
blood cells (hRBC) suspension and were incubated for 30 min
at 37◦C. Hemolytic activities were measured by monitoring the
absorbance at 420 nm.
Statistical Analysis
Unless otherwise noted, the results are presented as the
mean ± SEM. One-way analysis ANOVA of variance, followed
by Tukey post hoc analysis was used for statistical analysis. The
results were considered to be statistically significant if p< 0.01.
RESULTS
We have previously reported the first five synthetic peptidic
inhibitors of B. cereus PlcR-PapR QS system; three independent
alanine amino acid replacements (PapR7 – P4A, E6A, and F7A)
and two D-amino acid substitutions (PapR7 – dE6 and dF7)
showed great reduction of PlcR regulon expression and virulence
factor secretion (Yehuda et al., 2018).
We initiated the current study by evaluating the three crucial
positions of the heptapeptide PapR -proline (Pro4), glutamic
acid (Glu6) and phenylalanine (Phe7) through systematic single
or/and multiple amino acid substitution strategy. We designed,
synthesized and purified a second generation set of PapR7-
derived peptide combinations to further explore the structure–
activity relationship delineated previously for the first-generation
of peptidic analogs. This set included twelve peptides with
double and triple alanine and D-amino acid replacements, at the
crucial Pro4, Glu6 and Phe7 residues (Supplementary Table S1,
Supplementary Figure S1 and Figure 1).
We scanned each of PapR7-derived peptide combinations for
its ability to modulate the expression of the PlcR regulon using
B. thuringiensis 407 Cry− (Bt 407−) as a model bacterium for the
B. cereus group. This strain cured of its plasmid is acrystalliferous
and shows high phylogenic similarity with the B. cereus reference
strain ATCC 14579 (Lereclus et al., 1989; Priest et al., 1994; Slamti
and Lereclus, 2005). Two lacZ-based reporter strains were used in
the current study, B. thuringiensis 407− plcA′Z (Bt A’Z) and PapR-
null mutant B. thuringiensis 407− 1papR plcA′Z (Bt1papR A’Z).
Both reporter strains contain a transcriptional fusion between the
plcA promoter region and the lacZ gene. plcA is a member of
the PlcR regulon and its expression directly reflects the activity
of PlcR. The activity of each PapR7-derived peptide combination
was evaluated and compared to the previously described five
B. cereus inhibitory synthetics PapR7-derived peptides (PapR7-
P4A; E6A; F7A; dE6 and dF7; Yehuda et al., 2018).
We first conducted an initial screening of all the analogs at
high peptide concentration (5 µM) in order to evaluate their
ability to activate the PlcR regulon to a level comparable to the
synthetic PapR7 signal peptide (Figure 2). Both first and second
generations of PapR7 analogous were classified by their number
of amino acid replacements (alanine or D-amino); single, double
and triple. Similar to our first-generation single replacement
inhibitors, none of the new PapR7-derived peptide combinations
were capable of activating the PlcR regulon. These findings
revealed that any alanine and D-amino acid replacements, at the
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FIGURE 1 | Second generation of PapR7-derived peptide combinations. (A) Sequences of first generation potent synthetic inhibitors 7-mer PapR-derived peptides
(PapR7; ADLPFEF) involved D-amino acid or alanine replacements at three positions; proline (P) glutamic (E), and phenylalanine (F) of the heptapeptide PapR.
(B) Sequences of second generation of PapR7-derived peptide combinations, involved double and triple alanine and D-amino acids replacement.
FIGURE 2 | PlcR regulon activation by the new PapR7-derived peptide
combinations. β-galactosidase activity of Bt 1papR A’Z induced by the
addition of 5 µM PapR7-derived peptides normalized to synthetic PapR7
signal peptide at onset of the stationary phase of bacterial growth (OD600 of
3 ± 0.5, mean ± SEM, n = 9). ∗p < 0.01 indicates a statistically significant
difference between addition of synthetic PapR7 peptide and PapR7-
derived peptides.
positions Pro4, Glu6 and Phe7 of PapR7 derivatives, are critical
for PlcR regulon activation. These derivatives can therefore be
classified as potential candidates for the development of potent
second-generation PlcR inhibitors.
We next scrutinized their ability to compete with the
endogenous PapR signal peptide (in Bt A’Z reporter strain) for
reducing the activation of the PlcR regulon in late-exponential
phase of bacterial growth (OD600 of 1.8 ± 0.1). As shown
in Figure 3A; PapR7 derivatives activities were classified by
D-amino acid enantiomer or Ala replacements at either of
the three PapR7 crucial positions (Pro4, Glu6 and Phe7).
The previously reported inhibitors, PapR7-P4A; E6A; F7A;
dE6 and dF7, were also included for comparison. Peptides
PapR7 – P4A:E6A, P4A:E6A:F7A and P4A:E6A:dF7 did not
show any reduction in plcA’Z activity. PapR7 – E6A:F7A,
E6A:dF7, P4A:F7A, P4A:dE6, P4A:dF7, PapR7 – P4A:dE6:dF7
and P4A:dE6:F7A were able to reduce plcA’Z activity by
approximately 40%. We identified two candidate peptides that
inhibited plcA’Z activation when added at late-exponential phase.
Indeed, PapR7 – dE6:dF7 and dE6:F7A reduced plcA’Z activity
by 71 and 65 %, respectively, similarly to the inhibitory activity
of their parent reporter inhibitors PapR7 – dE6, dF7 and F7A
(65, 63, and 70%, respectively). To confirm PapR7 – dE6:dF7
and dE6:F7A potent inhibition, we repeated the experiment
with several concentrations of these inhibitors in order to
determine their IC50 values (Figures 3B,C). The results show
that the new inhibitory peptides have IC50 values in the low
micromolar range, almost comparable to their parent reporter
inhibitors IC50 values (Table 1). Overall, we identified new
potent inhibitors, PapR7 – dE6:dF7 and dE6:F7A, which were
able to compete with endogenous PapR and inhibit PlcR
regulon activity very effectively. Interestingly, these two potent
inhibitors contain D-Glutamic acid replacement at position 6 of
the PapR heptapeptide.
We have previously reported that inhibition through PapR7
inhibitory peptidic derivatives is cell density dependent (Slamti
and Lereclus, 2002; Yehuda et al., 2018). To examine the effect
of bacterial cell density on the inhibition of the PlcR regulon
expression, each derivative was added to Bt A’Z cells at OD600
0.1 ± 0.03, which corresponds to the early stage of exponential
phase. PlcR-dependent gene expression was then quantified after
2.5 h (Figure 4) and after 24 h in order to assess their activity
and stability over time (Supplementary Figure S2). As has been
reported recently, all of our known parent PapR7 inhibitors
were able to completely block plcA’Z activation for up to 24 h
under these conditions (Yehuda et al., 2018). We observed
similar results with PapR7 – dE6:dF7 and dE6:F7A; these peptides
blocked plcA’Z activation compared to the parent peptidic
inhibitors for 2.5 h and up to 24 h (Figure 4 and Supplementary
Figure S2). Combining them with additional alanine replacement
at Pro4, PapR7 – P4A:dE6:dF7 and P4A:dE6: F7A showed a
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FIGURE 3 | Competition studies with new PapR7-derived peptide combinations. (A) β-galactosidase activity of Bt A’Z induced by the addition of 2.5 µM
PapR7-derived peptides, (B) PapR7- dE6:dF7, and (C) PapR7-dE6:F7A derivatives in several concentrations normalized to untreated bacterial cells at
late-exponential of bacterial growth (OD600 of 1.8 ± 0.1, mean ± SEM, n = 9). ∗p < 0.01 indicates a statistically significant difference between untreated Bt A’Z and
addition of PapR7-derived peptides. Different letters indicate statistically significant differences between PapR7-derived peptide treatments (p < 0.01).
reduction of ∼75% in plcA’Z activation. The addition of PapR7
derivatives as PapR7- E6A:F7A, E6A:dF7, P4A:F7A, P4A:dE6 and
P4A:dF7 in the early stages of the bacterial growth led to drastic
reduction in plcA’Z activity, revealing a series of new peptidic
inhibitors. In contrast, the non-inhibitory peptidic combinations
(PapR7- P4A:E6A, P4A:E6A:F7A and P4A:E6A:dF7) did not
reduce the PlcR regulon expression even in low bacterial density.
Importantly, the bacterial growth was not affected by the addition
of all the examined peptides (data not shown).
Throughout these competition studies, we identified a group
of three non-inhibitory peptidic combinations (PapR7- P4A:E6A,
P4A:E6A:F7A and P4A:E6A:dF7), seven variants of PapR7
containing multiple replacements combinations with median to
high inhibitory activities (PapR7- P4A:dE6:F7A, P4A:dE6:dF7,
E6A:F7A, E6A:dF7, P4A:F7A, P4A:dE6 and P4A:dF7) and two
very potent inhibitors that abolish activation of plcA’lacZ (PapR7
– dE6:dF7 and dE6:F7A) and compete with endogenous PapR.
These two peptides are proposed as quorum quenchers that
TABLE 1 | Comparison between IC50 values of new PapR7-derived peptide
combinations and their parent inhibitors, as determined by the
lacZ-based reporter assay.
Ic50[µM]∗
PapR7-dE6:dF7 1.675 ± 0.170a PapR7-dE6 0.977 ± 0.042c
PapR7-dE6:F7A 2.566 ± 0.203b PapR7-dF7 1.223 ± 0.072ac
PapR7-F7A 1.675 ± 0.102a
∗ IC50 values were calculated by GraphPad Prism 8, using the non-linear
inhibitor vs. normalized response method. Different letters indicate statistically
significant differences between IC50 values of PapR7-derived peptide combinations
(p < 0.01).
FIGURE 4 | Exploring the effect of bacterial cell density on the PapR7-derived
peptide combinations activity. β-galactosidase activity of Bt A’Z induced by
the addition of 10 µM PapR7-derived peptides normalized to untreated
bacterial cells at end lag phase of bacterial growth (OD600 of 0.1 ± 0.03;
mean ± SEM, n = 9). ∗p < 0.01 indicates a statistically significant difference
between untreated Bt A’Z and addition of PapR7-derived peptides. Different
letters indicate statistically significant differences between PapR7-derived
peptide treatments (p < 0.01).
do not affect the bacterial growth but inhibit the expression of
the PlcR regulon.
After observing this inhibitory activity, we expanded our study
to explore the effect of these second generation PapR7 analogs
on the production of a representative virulence factor under
the control of PlcR in wild-type bacteria. Previous studies have
shown that the activity of hemolysins in B. cereus is regulated
by the PlcR – PapR QS system (Salamitou et al., 2000; Slamti
and Lereclus, 2002; Slamti et al., 2004). Therefore, we studied
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the effect of the new PapR7 derivatives on the production of
hemolysins in B. cereus strain ATCC 14579, a representative
member of the B. cereus sensu stricto species.
We performed hemolytic activity assays toward human
red blood cells in the presence of the synthetic derivatives
(Figure 5A). From these results, we identified PapR7 inhibitory
peptidic analogs that were able to reduce the hemolytic activity
of wild type B. cereus ATCC 14579. Interestingly, these analogs
reduced the expression of hemolysin (Figure 5A) even more
efficiently than the inhibition that was observed for Bt 407−
PlcR-dependent gene expression (as shown in Figure 4). We
quantified the hemolytic activity of the strong inhibitors group
by determining their IC50 values. In addition to the two strong
inhibitors derivatives (PapR7 – dE6:dF7, dE6:F7A), we observed
great activity also for PapR7 – P4A:dE6:dF7 and P4A:dE6:F7A
analogs. Regard to PapR7 – dE6:dF7 and dE6:F7A derivatives,
the relative IC50 value trends were highly similar to those in
the lacZ-reporter assays results (Figure 5B and Tables 1, 2).
In comparison to their parent single inhibitors PapR7 – dF7
and F7A, the relative IC50 values were in the same range
(Figures 5B,C and Table 2); addition of D- Glutamic acid in
the parent peptide PapR7 – dF7 (PapR7 – dE6:dF7) slightly
improved its IC50 (IC50 value was reduced to 1.382 compared
to 3.041), while alanine substituted at position Phe7 (PapR7 –
dE6:F7A) did not show any effect. PapR7– P4A:dE6:dF7 and
P4A:dE6:F7A exhibited lower IC50 values compared to their
parent single inhibitors PapR7– P4A, dF7 and F7A but a
higher IC50 value compared to the parent peptide PapR7–
dE6 (Table 2). We observed another key feature in the new
PapR7 combinations; sharing specific substitutions at PapR7
sequence influence their ability to inhibit PlcR activity; for
example, all non-inhibitory peptidic combinations included
alanine substitutions at positions Pro4 and Glu6 of PapR7
peptide, while all strong inhibitors group members share
replacement of Glu6 by its D-isomer. All these new PapR7
combinations activity profiles may shed light on PlcR and PapR
interaction. To better understand their role in PlcR activity, we
divided the delineated above (Figure 5) PapR7-derived peptidic
combinations hemolytic activities on human red blood cells to
three different sets (Figures 6A–C).
TABLE 2 | Comparison between IC50 values of new PapR7-derived peptide
combinations and their parent inhibitors, as determined by the hemolytic assay.
IC.50 values [µM]∗
PapR7-dE6:dF7 1.382 ± 0.117ab PapR7-dE6 1.053 ± 0.089a
PapR7-dE6:F7A 2.497 ± 0.212cd PapR7-dF7 3.041 ± 0.206cd
PapR7-F7A 2.725 ± 0.239d
PapR7 - P4A: dE6: dF7 2.141 ± 0.148b−d PapR7-P4A 4.391 ± 0.288e
PapR7-P4A: dE6: F7A 1.994 ± 0.184a−c PapR7-dE6 1.053 ± 0.089a
PapR7-dF7 3.041 ± 0.206cd
PapR7-F7A 2.725 ± 0.239d
∗ IC50 values were calculated by GraphPad Prism 8, using the non-
linear inhibitor vs. normalized response method. Different letters indicate
statistically significant differences between IC50 values of PapR7-derived peptide
combinations (p < 0.01).
SUMMARY
Role of Individual and Combined Pro4 or
Glu6 Residue Replacements
Replacing both Pro4 and Glu6 in PapR7 with alanine yielded non-
active peptidic combinations regardless of other modifications
in Phe7 position (PapR7- P4A:E6A, P4A:E6A:F7A, and
P4A:E6A:dF7; Figure 6A). PapR7- P4A:E6A:F7A and P4A:E6A
are non-inhibitory peptides, while PapR7- E6A:F7A and
P4A:F7A defined as medium inhibitors, reduce the hemolytic
activity by ∼60%. The same trend was observed with other two
non-inhibitory peptidic combinations; PapR7- P4A:E6A:dF7
and PapR7- P4A:E6A compared to their disassembled peptidic
combinations PapR7- E6A:dF7, P4A:dF7 and PapR7- P4A, E6A,
respectively. These findings verified the dependence of proline
and glutamic acid residues in PapR7 inhibitory activity. By
modifying these two residues together to alanine the PapR7-
derived inhibitors lost their antagonist features and their ability
to prevent native PapR-PlcR interaction. This is in agreement
with previous study (Bouillaut et al., 2008; Grenha et al., 2013),
which emphasizes that both proline and glutamic acid have an
important role in PlcR activation.
Effect of Phe7 Replacement
Crystal structure of PapR7- PlcR complex showed that both
PapR7 phenylalanine residues (Positions 5 and 7) are located
in hydrophobic pockets (Grenha et al., 2013), and involved in
hydrophobic interactions with PlcR. We examined the effect of
replacing Phe7 with alanine or D-amino acid on the inhibitory
activities of the designed peptides. Introducing D-Phenylalanine
at position 7, regardless to the modifications at position 4
and 6, enhances the inhibitory activity of PlcR (Figure 6B).
Replacing F7 in alanine (PapR7 – E6A:F7A or P4A:F7A) reduced
hemolysis of red blood cells by 60%. However, these replacements
combined with D-Phenylalanine yielded analogs (PapR7 –
E6A:dF7 and P4A:dF7) with stronger antagonistic activities
(approximately 83% inhibition). These results indicate that the
inclusion of D-Phenylalanine may contribute to hydrophobic
interactions with PlcR by preserving the aromatic ring side
chain interaction.
Importance of Glu6 and Its Stereoisomer
Substitution
We observed that all the strong inhibitor group members contain
the replacement of Glu6 to its D-enantiomer (Figure 5A).
PapR7 – dE6:F7A and dE6:dF7 displayed similar inhibitory
effect, regardless of other modifications (D-amino or alanine
replacements) in position Phe7 (Figure 6C). In contrast,
replacing Glu6 with alanine yielded two weaker PlcR
antagonists, when either Phe7 combined substitutions with
alanine or D-amino (PapR7 – E6A:F7A and E6A:dF7). PapR7
– P4A:dE6:F7A and P4A:dE6:dF7 fully prevented hemolysis
of red blood cells, however, replacing only Glu6 with alanine
yielded two non-inhibitory peptidic combinations PapR7-
P4A:E6A:F7A and P4A:E6A:dF7 as was supported by IC50
values (Figure 6D).
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FIGURE 5 | New PapR7-derived peptide combinations inhibit Bc virulence factor. (A) Hemolytic activity on human red-blood cells of supernatant B. cereus ATCC
14579 treated cultures in 10 µM of PapR7-derived peptides normalized to untreated bacterial cells at end lag phase of bacterial growth (OD600 of 0.1 ± 0.03;
mean ± SEM, n = 9). Hemolysis inhibition dose response curves of B. cereus ATCC 14579 treated supernatant cultures in different concentrations of (B) PapR7 –
dE6:dF7, dE6:F7A, P4A:dE6:dF7, and P4A:dE6:F7A and (C) known inhibitors normalized to untreated bacterial culture (mean ± SEM, n = 9). ∗p < 0.01 indicates a
statistically significant difference between untreated B. cereus ATCC 14579 and addition of PapR7-derived peptides. Different letters indicate statistically significant
differences between PapR7-derived peptide treatments (p < 0.01).
FIGURE 6 | Exploring specific combination replacements effect on Bc virulence inhibition. Hemolytic activity of supernatant B. cereus ATCC 14579 treated cultures in
10 µM of PapR7-derived peptides normalized to untreated supernatants of bacterial cells at end lag phase of bacterial growth (OD600 of 0.1 ± 0.03; mean ± SEM,
n = 9). Hemolytic activities on human red blood cells were classified by exploring the role of three PapR7 crucial positions in PlcR activity; (A) Role of individual and
combined Pro4 or Glu6 residue replacements. (B) Effect of Phe7 replacement. (C) Importance of Glu6 and its stereoisomer substitution. Hemolysis inhibition dose
response curves of B. cereus ATCC 14579 treated supernatant cultures in different concentrations of (D) PapR7 – P4A:E6A:dF7 and P4A:dE6:dF7 normalized to
untreated bacterial culture (mean ± SEM, n = 9). Different letters indicate statistically significant differences between PapR7-derived peptide treatments (p < 0.01).
Interestingly, in an earlier study (Bouillaut et al., 2008;
Grenha et al., 2013) the authors characterized the function
and specific interactions of PapR glutamic acid with conserved
residues in PlcR. These findings support our results about the
important role of Glu6 in the activity of PlcR regulon. Indeed,
replacement of L-glutamic acid of PapR7- P4A:F7A and P4A:dF7
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(corresponding ADLAFEA and ADLAFEdF), with D-glutamic
acid yielded two potent PlcR antagonists; PapR7- P4A:dE6:F7A
and P4A:dE6:dF7. Overall, these three sets of new PapR7-derived
peptide combinations support previous published studies and
reveal the important role of three crucial positions at designing
potent PlcR antagoinsts; Pro4, Phe7 and especially Glu6 that
may function to selectively allow PapR, but not other similar
autoinducers, to bind PlcR.
CONCLUSION
The PapR-PlcR QS system is extensively involved in the
pathogenesis of B. cereus, highlighting this system as an attractive
target for an alternative treatment to prevent infection. We
have previously reported the first five potent synthetic peptidic
inhibitors of B. cereus PlcR-PapR QS system (Yehuda et al.,
2018); three independent alanine amino acid replacements
(PapR7 - P4A, E6A, and F7A) and two D-amino acid
substitutions (PapR7 – dE6 and dF7). We concluded that
the critical residues for PapR7 –PlcR interaction and PlcR
activation were proline, glutamic acid and phenylalanine. To
further understand their role in PlcR activity, a new set
of PapR7 analogs with double and triple alanine and D-
amino acid replacements at these positions were designed
and synthesized. Multiple amino acid substitutions revealed
that any replacement at these positions Pro4, Glu6 and Phe7
of PapR7 derivatives, is critical for PlcR regulon activation
in the 1papR mutant strain. A comprehensive competition
study of all PapR7-derived peptides combinations in late-
exponential phase identified four promising QS peptidic
inhibitors candidates; PapR7 – dE6:dF7 and dE6:F7A and
two other analogs with additional alanine substituted PapR7
– P4A:dE6:dF7 and P4A:dE6:F7A, all contained D-Glutamic
acid at position 6 of the C-terminus of heptapeptide PapR.
The two potent inhibitors PapR7 – dE6:dF7 and dE6:F7A
generated similar inhibitory activity as their parent single
replacement reported inhibitors PapR7 – dE6, dF7 and F7A
with comparable IC50 values ∼= 1–2.6 µM. Our results verified
previous reports that inhibition through PapR7 derivatives is
cell density dependent (Slamti and Lereclus, 2002; Yehuda
et al., 2018). We showed that all of our new four promising
QS peptidic inhibitors candidates blocked the PlcR regulon
activity even after 24-h period, when they were added at an
early stage of bacterial growth (PapR7 – dE6:dF7, dE6:F7A,
PapR7 – P4A:dE6:dF7, and P4A:dE6:F7A). Moreover, by exposing
the bacterial cells to these analogs at earlier stage (OD600
0.1 ± 0.03) we discovered a new series of inhibitors (PapR7-
E6A:F7A, E6A:dF7, P4A:F7A, P4A:dE6, and P4A:dF7). Similar
to the parent peptidic inhibitors, we hypothesized that the
positive autoregulatory loop was blocked and quorum quenching
was achieved throughout growth by the inhibitory multiple
combinations PapR7 derivatives.
We next used a human red-blood cells hemolytic assay as
a direct method to assess a QS-related phenotype linked to
virulence in wild-type B. cereus. The inhibitory PapR7 peptidic
analogs identified using the lacZ-reporter assays were even
more efficient in reducing the hemolytic activity of wild type
B. cereus ATCC 14579.
Our findings both corroborate and extend previous
observations regarding the role of the PapR7 in PlcR receptor
recognition; first, we showed the important role of proline
or glutamic acid residues in PapR- PlcR interactions and as
key in designing strong inhibitors. Second, we demonstrated
that inclusion of D-Phenylalanine at Phe7 contribute to
PapR7 derivatives inhibitory activities probably due to its
hydrophobic features. Moreover, by interfering this Glu6
specific interactions with PlcR, we found the potential of
D-Glutamic substitution at designing potent PlcR antagonist.
These findings are consistent with previous study (Slamti and
Lereclus, 2005) which investigated specificity and polymorphism
of PlcR – PapR in the B. cereus group. Interestingly, while
all the PapR sequences from different strains of the B. cereus
group showed divergences in their three N-terminal residues,
the E6 position was conserved. In the current study we
highlighted the precise and unpredictable engineering of
natural pheromone in our effort to develop new Quorum
Quenching agents, reflecting the trade-off between good
peptide binding and lower activation. These new non-native
peptides inhibitors may be applied as chemical tools to further
study the role of PlcR and other QS in all B. cereus group
members. Further, our method of single and multiple amino acid
replacements might be applied to other QS system to design new
anti-virulence agents.
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